344 related articles for article (PubMed ID: 30045685)
1. Hypercoagulable states in arterial and venous thrombosis: When, how, and who to test?
Carroll BJ; Piazza G
Vasc Med; 2018 Aug; 23(4):388-399. PubMed ID: 30045685
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based indications for thrombophilia screening.
Lindhoff-Last E; Luxembourg B
Vasa; 2008 Feb; 37(1):19-30. PubMed ID: 18512539
[TBL] [Abstract][Full Text] [Related]
3. A novel mutation of antithrombin deficiency in six family siblings and the clinical combat.
Nadir Y; Hoffman R; Corral J; Barak Y; Hasin T; Keren-Politansky A; Brenner B
Thromb Haemost; 2015 Oct; 114(4):859-61. PubMed ID: 26177694
[No Abstract] [Full Text] [Related]
4. Peripheral arterial disease and thrombophilia.
Müller-Kolck U
Vasa; 2008 May; 37(2):189; author reply 190-2. PubMed ID: 18622971
[No Abstract] [Full Text] [Related]
5. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R
Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of thrombophilia.
García de Frutos P
Thromb Haemost; 2007 Sep; 98(3):485-7. PubMed ID: 17849035
[No Abstract] [Full Text] [Related]
7. [Thrombophilic disorders in venous thromboembolism. The clinical perspective].
Schmidt B; Schellong S
Med Klin (Munich); 2003 Mar; 98(3):133-9. PubMed ID: 12647087
[TBL] [Abstract][Full Text] [Related]
8. Uncertain thrombophilia markers.
Franchini M; Martinelli I; Mannucci PM
Thromb Haemost; 2016 Jan; 115(1):25-30. PubMed ID: 26271270
[TBL] [Abstract][Full Text] [Related]
9. Thrombophilias: when should we test and how does it help?
Whitlatch NL; Ortel TL
Semin Respir Crit Care Med; 2008 Feb; 29(1):25-39. PubMed ID: 18302084
[TBL] [Abstract][Full Text] [Related]
10. Clinical Impact of Thrombophilia Screening in Young Adults with Ischemic Stroke.
Omran SS; Lerario MP; Gialdini G; Merkler AE; Moya A; Chen ML; Kamel H; DeSancho M; Navi BB
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):882-889. PubMed ID: 30595511
[TBL] [Abstract][Full Text] [Related]
11. Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review.
Bertoletti L; Benhamou Y; Béjot Y; Marechaux S; Cheggour S; Aleil B; Lellouche N; Dillinger JG; Delluc A
Blood Rev; 2018 Jul; 32(4):272-279. PubMed ID: 29402471
[TBL] [Abstract][Full Text] [Related]
12. An Unexpectedly High Rate of Thrombophilia Disorders in Patients with Superficial Vein Thrombosis of the Lower Extremities.
Sobreira ML; Rogatto SR; Dos Santos RM; Santos IT; Ferrari IC; Yoshida WB
Ann Vasc Surg; 2017 Aug; 43():272-277. PubMed ID: 28501666
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the thrombophilia paradox: from hypercoagulability to the prothrombotic state.
Baglin T
J Thromb Haemost; 2010 Feb; 8(2):228-33. PubMed ID: 19943876
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
[TBL] [Abstract][Full Text] [Related]
15. D-dimer levels, constitutional thrombophilia, and venous thrombosis prediction: clinical aspects and implications.
Samama MM; Horellou MH; Elalamy I; Mathieux V; Ombandza-Moussa E; Conard J
Semin Vasc Med; 2005 Nov; 5(4):371-4. PubMed ID: 16302158
[TBL] [Abstract][Full Text] [Related]
16. Thrombophilia and venous thromboembolism: implications for testing.
Cohn DM; Roshani S; Middeldorp S
Semin Thromb Hemost; 2007 Sep; 33(6):573-81. PubMed ID: 17768689
[TBL] [Abstract][Full Text] [Related]
17. Thrombophilia and arterial disease. An up-to-date review of the literature for the vascular surgeon.
Böhm G; Al-Khaffaf H
Int Angiol; 2003 Jun; 22(2):116-24. PubMed ID: 12865876
[TBL] [Abstract][Full Text] [Related]
18. Warfarin Dosing and Time Required to Reach Therapeutic International Normalized Ratio in Patients with Hypercoagulable Conditions.
Kahlon P; Nabi S; Arshad A; Jabbar A; Haythem A
Turk J Haematol; 2016 Dec; 33(4):299-303. PubMed ID: 27093959
[TBL] [Abstract][Full Text] [Related]
19. Reduced fibrinolysis and increased fibrin generation can be detected in hypercoagulable patients using the overall hemostatic potential assay.
Curnow JL; Morel-Kopp MC; Roddie C; Aboud M; Ward CM
J Thromb Haemost; 2007 Mar; 5(3):528-34. PubMed ID: 17166248
[TBL] [Abstract][Full Text] [Related]
20. Arterial thrombosis and the role of thrombophilia.
Boekholdt SM; Kramer MH
Semin Thromb Hemost; 2007 Sep; 33(6):588-96. PubMed ID: 17768691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
